Noopept
Also: N-phenylacetyl-L-prolylglycine ethyl ester
Russian-developed prescription nootropic with strong anecdotal cognitive reports.
Evidence
emerging
Legal status
research only
Half-life
~30 minutes (prodrug)
Routes
oral
What it is
Noopept is a prodrug of cycloprolylglycine and is reported to enhance memory, focus, and recovery from neurological insult. Widely used as a research nootropic outside Russia.
Mechanism
Increases BDNF and NGF expression; modulates AMPA/NMDA glutamate signaling.
Outcomes it's matched to
- STRENGTH65%
Safety
Generally well tolerated; irritability and headaches reported.
- Pregnancy
Legal context
Prescription compound in Russia; research use only in Western markets.